BEN 8744
Alternative Names: BEN-8744Latest Information Update: 25 Apr 2024
At a glance
- Originator BenevolentAI
- Class Anti-inflammatories; Small molecules
- Mechanism of Action Phosphodiesterase 10A inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Phase I Ulcerative colitis
- Preclinical Crohn's disease